Stock

20 stories about Stock
הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Anchiano Therapeutics Schedules TASE Delisting

14.03.19|Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
נאסדק

Starboard Divests Mellanox Stake Ahead of Deal Completion

13.03.19|Golan Hazani
On Monday, Nvidia announced an acquisition agreement to buy Mellanox for $6.9 billion. On Tuesday, Starboard revealed it has sold its remaining stake
רועי סבג בלוקצ'יין כרייה משאבי טבע

Crypto Mining Outfit Bitfarms to Depreciate $19 Million as Founder Denounces Bitcoin

11.03.19|Tzally Greenberg
Founder and former CEO Roy Sebag twitted on Wednesday that he has sold all of his bitcoin assets barring his 22.5% Bitfarms stake
יו" סטרטסיס והמנכ"ל בפועל אלחנן יגלום

U.S. Government Shutdown Tanked Fourth Quarter Sales, Says Stratasys

10.03.19|Hezi Sternlicht
Stratasys manufacturers 3D printers and production systems for several industries, including aerospace, automotive, healthcare, and consumer products
מימין אביחי רמות מנהל מפעל Flex  אופקים רמי רשף מנכל GenCell

Fuel Cell Startup GenCell Considering IPO

07.03.19|Golan Hazani
Israel-based GenCell develops fuel cells capable of converting hydrogen and ammonia into hydrogen fuel
מנכ"ל טבע קאר שולץ קור שולץ קר שולץ מנכ"ל טבע פברואר 2018

Morgan Stanley Downgrades Teva From Overweight to Equal Weight

07.03.19|Hezi Sternlicht
The bank upgraded Teva to overweight in November, setting a target price of $27, at the time a 20% premium on the company’s trading price
נאסדק

Top Image Filing Reveals Kofax's Initial Offer Was Higher

05.03.19|CTech
In February, Nasdaq-listed content processing solutions company Top Image announced Kofax agreed to acquire it for $16 million
איתמר מדיקל WatchPAT

Itamar Medical Starts Trading ADS on Nasdaq

27.02.19|Lilach Baumer
The Tel Aviv-listed medical diagnosis company received SEC approval for listing its ADS on the American exchange
סרטן שד גידול הקפאה אייסקיור

Cancer Freezing Company IceCure Raises Just Third of Planned Offering

21.02.19|Tzally Greenberg
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue
מאיר מועלם מנכ"ל ו מנכ"ל SAS

ASX-Listed Satellite Company SAS to Raise A$12 Million

20.02.19|Lilach Baumer
Sky and Space Global uses nano-satellite technology to offer communications services for telecommunications providers
הדוגמנית קרלי קלוס היא פרזנטורית של ויקס

Wix Beats Analyst Consensus on Quarterly, Annual Revenues

20.02.19|Lilach Baumer
The Israeli website building company closed 3.48% up on Nasdaq Tuesday
מנכ"ל טאואר ראסל אלוונגר

Earnings Report Boosts Tower Semiconductor on Nasdaq Despite Cut to Profits

20.02.19|Hezi Sternlicht
Tower lost around 50% of its stock valuation over the past 12 months
נאסדק

Nice Reports Record Revenues for 2018, Bolstered by Cloud Offering

14.02.19|Lilach Baumer
The company benefited from a 28% year-over-year increase in revenues for its cloud segment, which reached $461 million for the full year
קאר שולץ מנכל טבע

Teva’s Schultz is Running Out of Rope

14.02.19|Hezi Sternlicht
In the fourth quarter and annual earnings reported by the company Wednesday, Teva missed analyst consensus for non-GAAP earnings per share, and shareholders seem to be losing patience
מנכ"ל טבע החדש קור שולץ 2

Teva to Close 11 More Manufacturing Facilities in 2019

14.02.19|Lilach Baumer
The drugmaker published its fourth quarter and annual reports Wednesday, dropping almost 8% on NYSE after forecasting a steep cut in profits for 2019
אסף אלימלך מנכ"ל Plus500

Trading Firm Plus500 Crashes on Profit Warning

12.02.19|Lilach Baumer
Despite increased revenues in 2018, measures adopted by the European Securities and Markets Authority regarding the industry are "likely to result in 2019 profit being materially lower,” the company stated
משרדי אמדוקס ב רעננה AMDOCS

Amdocs Reports $1.01 Billion in Revenue For First Quarter of Fiscal 2019

06.02.19|Tofi Stoler
The results were slightly above the midpoint of the company’s $990 million to $1.03 billion guidance range for the quarter
נאסדק

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
מריחואנה קנאביס גראס 1

In Tel Aviv, Reform Sends Cannabis Stocks Down as Shareholders Sell High

28.01.19|Lilach Baumer
On Sunday, the Israeli government gave the final stamp of approval to a cannabis export reform. In response, Tel Aviv’s cannabis stocks tumbled
משרדי אמדוקס ב רעננה AMDOCS

Amdocs Stock Falls on Warning of Short-Seller Hedge Fund Spruce Point

24.01.19|Lilach Baumer
Amdocs closed 8.95% down on Nasdaq on Wednesday but is currently trending up